NCT02509481View on ClinicalTrials.gov

Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

2,712

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
MalariaLymphatic Filariasis
Interventions
DRUG

Ivermectin

DRUG

Albendazole

Trial Locations (2)

80523

Colorado State University, Fort Collins

10400-000

Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso

All Listed Sponsors
collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

collaborator

Centre Muraz

OTHER

collaborator

Ministère de la Santé du Burkina Faso

UNKNOWN

lead

Colorado State University

OTHER

NCT02509481 - Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study | Biotech Hunter | Biotech Hunter